Page last updated: 2024-08-16

rivastigmine and Sleep Wake Disorders

rivastigmine has been researched along with Sleep Wake Disorders in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Breuning, L; Dautzenberg, PLJ	1
Bozoglu, E; Cintosun, U; Doruk, H; Kocak, N; Naharci, MI; Ozturk, A; Tasci, I; Yasar, H	1
Lewis, SJ; Szeto, JY	1
Herrmann, N; Lanctôt, KL; Thompson, S	1
Beusterien, KM; Musher, J; Narayanan, S; Strunk, B; Thomas, SK	1
Ancoli-Israel, S; Cooke, JR; Corey-Bloom, J; Fiorentino, L; Harrison, T; Liu, L; Loredo, JS; Marler, M	1
Lacomblez, L	1
Grace, JB; McKeith, IG; Walker, MP	1

Reviews

2 review(s) available for rivastigmine and Sleep Wake Disorders

Article	Year
Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia. Current neuropharmacology, 2016, Volume: 14, Issue:4 Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Exercise Therapy; Galantamine; Humans; Indans; Memantine; Parkinson Disease; Piperidines; Rivastigmine; Sleep Wake Disorders; Treatment Outcome	2016
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert opinion on drug safety, 2004, Volume: 3, Issue:5 Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome	2004

Article

Year

Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.

Current neuropharmacology, 2016, Volume: 14, Issue:4

Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Exercise Therapy; Galantamine; Humans; Indans; Memantine; Parkinson Disease; Piperidines; Rivastigmine; Sleep Wake Disorders; Treatment Outcome

2016

The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.

Expert opinion on drug safety, 2004, Volume: 3, Issue:5

Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome

2004

Trials

1 trial(s) available for rivastigmine and Sleep Wake Disorders

Article	Year
Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs & aging, 2006, Volume: 23, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Polysomnography; Rivastigmine; Sleep Stages; Sleep Wake Disorders	2006

Other Studies

5 other study(ies) available for rivastigmine and Sleep Wake Disorders

Article	Year
[Rivastigmine as treatment for flashbacks and REM sleep problems in an older patient]. Tijdschrift voor psychiatrie, 2021, Volume: 63, Issue:1 Topics: Dreams; Female; Hallucinations; Humans; Incest; Middle Aged; Panic Disorder; Rivastigmine; Sleep Wake Disorders; Sleep, REM; Treatment Outcome	2021
Galantamine improves sleep quality in patients with dementia. Acta neurologica Belgica, 2015, Volume: 115, Issue:4 Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Indans; Male; Piperidines; Rivastigmine; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome	2015
Antipsychotic drug use among nursing home residents taking rivastigmine. Journal of the American Medical Directors Association, 2006, Volume: 7, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Cholinesterase Inhibitors; Drug Utilization Review; Female; Geriatric Assessment; Grief; Humans; Male; Mental Disorders; Nursing Homes; Phenylcarbamates; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Rivastigmine; Sleep Wake Disorders; Stress, Psychological; Surveys and Questionnaires; Treatment Outcome; United States	2006
[Drug therapy strategies in Alzheimer's disease]. La Revue du praticien, 1998, Nov-01, Volume: 48, Issue:17 Topics: Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Depression; Donepezil; Humans; Indans; Mental Disorders; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Sleep Wake Disorders; Tacrine	1998
A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease. International journal of geriatric psychiatry, 2000, Volume: 15, Issue:11 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Female; Humans; Lewy Body Disease; Male; Middle Aged; Phenylcarbamates; Polysomnography; Rivastigmine; Sleep Wake Disorders; Treatment Outcome	2000